Key facts
| Price (PPV) | 25 MAD |
|---|---|
| Composition (DCI) | chlorure de sodium |
| Class | Blood substitutes and perfusion solutions |
| ATC code | B05CB01 |
| Manufacturer | LAPROPHAN |
| Presentation | Poche de 1000 ml |
| Hospital price | 15.60 MAD |
| Data collected on | 9/8/2026 |
Indications
Rééquilibration ionique par apport de chlorure et de sodium ; · Déshydratation extracellulaire ; · Hypovolémie ; · Véhicule ou diluant de médicaments compatibles pour administration parentérale.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Chlorure De Sodium Laprophan 0.9 % (LAPROPHAN) contains the same active substance as Chlorure De Sodium Laprophan 0.9 % (Chlorure de sodium) at the same strength, but in a different pack: Poche de 250 ml at 13.50 MAD, i.e. 0.05 MAD per ml against 0.03 MAD for Chlorure De Sodium Laprophan 0.9 %. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Chlorure De Sodium Laprophan 0.9 % | LAPROPHAN | Poche de 250 ml | 13.50 MAD | 0.05 / ml |
| Chlorure De Sodium Laprophan 0.9 % | LAPROPHAN | Poche de 100 ml | 13.50 MAD | 0.14 / ml |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Chlorure De Sodium Laprophan 0.9 %
Chlorure De Sodium Laprophan 0.9 % belongs to the blood substitutes and perfusion solutions therapeutic class. In Morocco, this drug is marketed by LAPROPHAN and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Chlorure De Sodium Laprophan 0.9 %, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Chlorure De Sodium Laprophan 0.9 %
Answers to common questions from Moroccan patients about this drug.